ArticleFrontiers in immunology2026
High-fat diet-induced gut microbiota functional reprogramming is associated with metabolic inflammation and cardiac remodeling through the gut-heart axis in mice.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gut microbiota alterations have been implicated in the progression of metabolic syndrome (MetS), which increases the risk of cardiovascular disease (CVD) and is influenced by lifestyle factors. However, the specific gut microbiota changes and their functional roles in MetS remain incompletely understood. Aims: We aimed to identify key gut microbial taxa associated with MetS and to explore their potential functional implications. Methods: Six-week-old male C57BL/6J mice were fed a high-fat diet (HFD) or normal chow diet (NCD) for 16 weeks. Body weight and adiposity, metabolic parameters (fasting blood glucose, oral glucose tolerance test, and serum insulin), systemic inflammatory markers (IL-6, TNF-α, CRP, and high-sensitivity CRP), and cardiovascular phenotypes (total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol) were assessed. Cardiac remodeling was evaluated by heart weight-to-body weight ratio and myocardial histopathology using hematoxylin and eosin (H&E) and Masson's trichrome staining. Cecal contents were collected for 16S rRNA gene sequencing. Results: HFD feeding induced a MetS-like phenotype characterized by obesity, insulin resistance, dyslipidemia, systemic inflammation, and early cardiac remodeling in mice. 16S rRNA sequencing revealed significant alterations in gut microbial composition, including enrichment of inflammation-associated taxa such as Conclusion: Our findings suggest that HFD-induced Mets is associated with gut microbiota dysbiosis and functional remodeling, suggesting a potential involvement of microbiota-mediated metabolic pathways and host-microbiota interactions in cardiometabolic abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.